Genmab

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Genmab and other ETFs, options, and stocks.

About GMAB

Genmab A/S is an international biotechnology company, which engages in the development of human antibody therapeutics for the treatment of cancer and other diseases. Its product pipeline includes daratumumab, marketed as DARZALEX for the treatment of certain indications of multiple myeloma, teprotumumab-trbw marketed as TEPEZZA for the treatment of thyroid eye disease, and ofatumumab, marketed as Arzerra for the treatment of certain indications of chronic lymphocytic leukemia.

CEO

Jan G. J. van de Winkel

CEOJan G. J. van de Winkel

Employees

2,682

Employees2,682

Headquarters

Copenhagen, Central Denmark

HeadquartersCopenhagen, Central Denmark

Founded

1998

Founded1998

Employees

2,682

Employees2,682

GMAB Key Statistics

Market cap

13.38B

Market cap13.38B

Price-Earnings ratio

11.43

Price-Earnings ratio11.43

Dividend yield

—

Dividend yield—

Average volume

1.74M

Average volume1.74M

High today

$19.93

High today$19.93

Low today

$19.79

Low today$19.79

Open price

$20.20

Open price$20.20

Volume

40.86K

Volume40.86K

52 Week high

$31.88

52 Week high$31.88

52 Week low

$18.64

52 Week low$18.64

Analyst ratings

67%

of 27 ratings

Buy

66.7%

Hold

33.3%

Sell